{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T15:34:45Z","timestamp":1781883285463,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pulm Ther"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1007\/s41030-022-00193-w","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T09:03:09Z","timestamp":1660554189000},"page":"297-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment with the P2X3-Receptor Antagonist Gefapixant for Acute Cough in Induced Viral Upper Respiratory Tract Infection: A Phase 2a, Randomized, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"8","author":[{"given":"Jaclyn A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Kitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Noulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjela","family":"Tzontcheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan McGratty","family":"Seng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"key":"193_CR1","doi-asserted-by":"crossref","unstructured":"Irwin RS, French CL, Chang AB, Altman KW, Chest expert cough panel. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153:196\u2013209.","DOI":"10.1016\/j.chest.2017.10.016"},{"key":"193_CR2","doi-asserted-by":"crossref","unstructured":"Morice AH, McGarvey L, Pavord I, British Thoracic Society Cough Guideline Group. Recommendations for the management of cough in adults. Thorax. 2006;61(suppl 1):i1\u2013i24.","DOI":"10.1136\/thx.2006.065144"},{"key":"193_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4193\/Rhino14.149","volume":"53","author":"TJ Witek","year":"2015","unstructured":"Witek TJ, Ramsey DL, Carr AN, Riker DK. The natural history of community-acquired common colds symptoms assessed over 4-years. Rhinology. 2015;53:81\u20138.","journal-title":"Rhinology"},{"key":"193_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1164\/ajrccm\/138.2.305","volume":"138","author":"FJ Curley","year":"1988","unstructured":"Curley FJ, Irwin RS, Pratter MR, et al. Cough and the common cold. Am Rev Respir Dis. 1988;138:305\u201311.","journal-title":"Am Rev Respir Dis"},{"key":"193_CR5","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1164\/rccm.201209-1686OC","volume":"187","author":"KK Lee","year":"2013","unstructured":"Lee KK, Matos S, Evans DH, White P, Pavord ID, Birring SS. A longitudinal assessment of acute cough. Am J Respir Crit Care Med. 2013;187:991\u20137.","journal-title":"Am J Respir Crit Care Med"},{"key":"193_CR6","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1183\/09031936.00190111","volume":"41","author":"K Sunger","year":"2013","unstructured":"Sunger K, Powley W, Kelsall A, Sumner H, Murdoch R, Smith JA. Objective measurement of cough in otherwise healthy volunteers with acute cough. Eur Respir J. 2013;41:277\u201384.","journal-title":"Eur Respir J"},{"key":"193_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/j.1365-2710.1992.tb01289.x","volume":"17","author":"R Eccles","year":"1992","unstructured":"Eccles R, Morris S, Jawad M. Lack of effect of codeine in the treatment of cough associated with acute upper respiratory tract infection. J Clin Pharm Ther. 1992;17:175\u201380.","journal-title":"J Clin Pharm Ther"},{"key":"193_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1211\/0022357001774903","volume":"52","author":"PCL Lee","year":"2000","unstructured":"Lee PCL, Jawad MS, Eccles R. Antitussive efficacy of dextromethorphan in cough associated with acute upper respiratory tract infection. J Pharm Pharmacol. 2000;52:1137\u201342.","journal-title":"J Pharm Pharmacol"},{"key":"193_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1136\/bmj.324.7333.329","volume":"324","author":"K Schroeder","year":"2002","unstructured":"Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. BMJ. 2002;324:329\u201331.","journal-title":"BMJ"},{"key":"193_CR10","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1086\/367844","volume":"36","author":"JM Gwaltney Jr","year":"2003","unstructured":"Gwaltney JM Jr, Hendley JO, Patrie JT. Symptom severity patterns in experimental common colds and their usefulness in timing onset of illness in natural colds. Clin Infect Dis. 2003;36:714\u201323.","journal-title":"Clin Infect Dis"},{"key":"193_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2015-000118","volume":"3","author":"SK Atkinson","year":"2016","unstructured":"Atkinson SK, Sadofsky LR, Morice AH. How does rhinovirus cause the common cold cough? BMJ Open Respir Res. 2016;3: e000118.","journal-title":"BMJ Open Respir Res"},{"key":"193_CR12","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1128\/CMR.00077-12","volume":"26","author":"SE Jacobs","year":"2013","unstructured":"Jacobs SE, Lamson DM, St George K, Walsh TJ. Human rhinoviruses. Clin Microbiol Rev. 2013;26:135\u201362.","journal-title":"Clin Microbiol Rev"},{"key":"193_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2500\/105065895781874114","volume":"9","author":"SS Rao","year":"1995","unstructured":"Rao SS, Hendley JO, Hayden FG, Gwaltney JM Jr. Symptom expression in natural and experimental rhinovirus colds [abstract]. Am J Rhinol Allergy. 1995;9:49\u201352.","journal-title":"Am J Rhinol Allergy"},{"key":"193_CR14","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1128\/AAC.31.8.1183","volume":"31","author":"BM Farr","year":"1987","unstructured":"Farr BM, Conner EM, Betts RF, Oleske J, Minnefor A, Gwaltney JM Jr. Two randomized controlled trials of zinc gluconate lozenge therapy of experimentally induced rhinovirus colds. Antimicrob Agents Chemother. 1987;31:1183\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"193_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3920\/BM2016.0160","volume":"8","author":"RB Turner","year":"2017","unstructured":"Turner RB, Woodfolk JA, Borish L, et al. Effect of probiotic on innate inflammatory response and viral shedding in experimental rhinovirus infection\u2014a randomised controlled trial. Benef Microbes. 2017;8:207\u201315.","journal-title":"Benef Microbes."},{"key":"193_CR16","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/S0140-6736(14)61255-1","volume":"385","author":"R Abdulqawi","year":"2015","unstructured":"Abdulqawi R, Dockry R, Holt K, et al. P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet. 2015;385:1198\u2013205.","journal-title":"Lancet"},{"key":"193_CR17","doi-asserted-by":"publisher","first-page":"1901615","DOI":"10.1183\/13993003.01615-2019","volume":"55","author":"JA Smith","year":"2020","unstructured":"Smith JA, Kitt MM, Butera P, et al. Gefapixant in two randomised dose-escalation studies in chronic cough. Eur Respir J. 2020;55:1901615.","journal-title":"Eur Respir J"},{"key":"193_CR18","doi-asserted-by":"crossref","unstructured":"Smith JA, Kitt MM, Morice AH, et al, for the Protocol 012 investigators. Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial. Lancet Respir Med. 2020;8:775\u201385.","DOI":"10.1016\/S2213-2600(19)30471-0"},{"key":"193_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchemneu.2015.12.003","volume":"72","author":"SM Hermes","year":"2016","unstructured":"Hermes SM, Andresen MC, Aicher SA. Localization of TRPV1 and P2X3 in unmyelinated and myelinated vagal afferents in the rat. J Chem Neuroanat. 2016;72:1\u20137.","journal-title":"J Chem Neuroanat"},{"issue":"pt 3","key":"193_CR20","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1113\/jphysiol.2003.060079","volume":"556","author":"BJ Undem","year":"2004","unstructured":"Undem BJ, Chuaychoo B, Lee M-G, Weinreich D, Myers AC, Kollarik M. Subtypes of vagal afferent C-fibres in guinea-pig lungs. J Physiol. 2004;556(pt 3):905\u201317.","journal-title":"J Physiol"},{"key":"193_CR21","doi-asserted-by":"crossref","unstructured":"Kwong K, Kollarik M, Nassenstein C, Ru F, Undem BJ. P2X2 receptors differentiate placodal vs. neural crest C-fiber phenotypes innervating guinea pig lungs and esophagus. Am J Physiol Lung Cell Mol Physiol. 2008;295:L858\u201365.","DOI":"10.1152\/ajplung.90360.2008"},{"key":"193_CR22","doi-asserted-by":"publisher","first-page":"1900439","DOI":"10.1183\/13993003.00439-2019","volume":"54","author":"AH Morice","year":"2019","unstructured":"Morice AH, Kitt MM, Ford AP, et al. The effect of gefapixant, a P2X3 antagonist, on cough reflex sensitivity: a randomised placebo-controlled study. Eur Respir J. 2019;54:1900439.","journal-title":"Eur Respir J"},{"issue":"suppl 7","key":"193_CR23","first-page":"S708","volume":"6","author":"PV Dicpinigaitis","year":"2014","unstructured":"Dicpinigaitis PV. Effect of viral upper respiratory tract infection on cough reflex sensitivity. J Thorac Dis. 2014;6(suppl 7):S708\u201311.","journal-title":"J Thorac Dis"},{"key":"193_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.4168\/aair.2017.9.5.394","volume":"9","author":"WJ Song","year":"2017","unstructured":"Song WJ, Morice AH. Cough hypersensitivity syndrome: a few more steps forward. Allergy Asthma Immunol Res. 2017;9:394\u2013402.","journal-title":"Allergy Asthma Immunol Res"},{"key":"193_CR25","doi-asserted-by":"publisher","first-page":"2004271","DOI":"10.1183\/13993003.04271-2020","volume":"58","author":"JA Smith","year":"2021","unstructured":"Smith JA, Holt K, Dockry R, et al. Performance of a digital signal processing algorithm for the accurate quantification of cough frequency. Eur Respir J. 2021;58:2004271.","journal-title":"Eur Respir J"},{"key":"193_CR26","doi-asserted-by":"publisher","first-page":"175346662091515","DOI":"10.1177\/1753466620915155","volume":"14","author":"A Martin Nguyen","year":"2020","unstructured":"Martin Nguyen A, Bacci E, Dicpinigaitis P, Vernon M. Quantitative measurement properties and score interpretation of the Cough Severity Diary in patients with chronic cough. Ther Adv Respir Dis. 2020;14:1753466620915155.","journal-title":"Ther Adv Respir Dis"},{"key":"193_CR27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1745-9974-7-4","volume":"7","author":"N Yousaf","year":"2011","unstructured":"Yousaf N, Lee KK, Jayaraman B, Pavord ID, Birring SS. The assessment of quality of life in acute cough with the Leicester Cough Questionnaire (LCQ-acute). Cough. 2011;7:4.","journal-title":"Cough"},{"key":"193_CR28","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jclinepi.2004.11.019","volume":"58","author":"B Barrett","year":"2005","unstructured":"Barrett B, Brown R, Mundt M, et al. The Wisconsin Upper Respiratory Symptom Survey is responsive, reliable, and valid. J Clin Epidemiol. 2005;58:609\u201317.","journal-title":"J Clin Epidemiol"},{"key":"193_CR29","unstructured":"Barrett B. Wisconsin Upper Respiratory Symptom Survey\u2014WURSS-24\u2014Daily Symptom Report. 2006. https:\/\/www.fammed.wisc.edu\/files\/webfm-uploads\/documents\/research\/wurss-24.pdf. Accessed 3 Nov 2021."},{"key":"193_CR30","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","volume":"399","author":"L McGarvey","year":"2022","unstructured":"McGarvey L, Birring SS, Morice AH, et al. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, placebo-controlled phase 3 trials. Lancet. 2022;399:909\u201323.","journal-title":"Lancet."},{"key":"193_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2500\/105065896781794888","volume":"10","author":"RB Turner","year":"1996","unstructured":"Turner RB, Witek TJ, Riker DK. Comparison of symptom severity in natural and experimentally induced colds [abstract]. Am J Rhinol Allergy. 1996;10:167\u201372.","journal-title":"Am J Rhinol Allergy"},{"key":"193_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1164\/rccm.2109061","volume":"166","author":"JA Kastelik","year":"2002","unstructured":"Kastelik JA, Thompson RH, Aziz I, Ojoo JC, Redington AE, Morice AH. Sex-related differences in cough reflex sensitivity in patients with chronic cough. Am J Respir Crit Care Med. 2002;166:961\u20134.","journal-title":"Am J Respir Crit Care Med"},{"key":"193_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1136\/thx.2008.106237","volume":"64","author":"A Kelsall","year":"2009","unstructured":"Kelsall A, Decalmer S, McGuinness K, Woodcock A, Smith JA. Sex differences and predictors of objective cough frequency in chronic cough. Thorax. 2009;64:393\u20138.","journal-title":"Thorax"}],"container-title":["Pulmonary Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-022-00193-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41030-022-00193-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41030-022-00193-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T12:51:12Z","timestamp":1662641472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41030-022-00193-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1007\/s41030-022-00193-w","relation":{},"ISSN":["2364-1754","2364-1746"],"issn-type":[{"value":"2364-1754","type":"print"},{"value":"2364-1746","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}